CVE detail

CVE-2024-29129 — CVE-2024-29129

Published 2024-03-19 · Modified 2026-06-17 · Vendor oxyextras · Product oxyextras · Source nvd

HIGH

severity

CVSS-derived band

7.1

CVSS v3

0–10 scale

0.0037

EPSS probability

exploitation probability, 30d

30.0%

EPSS percentile

percentile vs all CVEs

NOT LISTED

CISA KEV

known exploited catalog

Description

Improper Neutralization of Input During Web Page Generation ('Cross-site Scripting') vulnerability in WPLIT Pty Ltd OxyExtras allows Reflected XSS.This issue affects OxyExtras: from n/a through 1.4.4.

Remediation

No vendor-published fix data in our corpus for this CVE. Check the references below or the vendor's PSIRT / security advisories page.

References

cvedb.io · NVD · CISA KEV · FIRST EPSS · vendor advisories (CVE Program List v5). Informational only, no warranty — verify every remediation against the vendor advisory before acting on it. This product uses data from the NVD API but is not endorsed or certified by the NVD, CISA, FIRST.org or any vendor named. CVE® is a registered trademark of The MITRE Corporation.